Participating in European research programs means expanding the horizon of innovation and working together with the best international centers to improve diagnosis, treatment and quality of life for patients. On this page we present the European projects to which IRCCS contributes its scientific and clinical expertise.
The European Comprehensive Cancer Centre Network
EUNetCCC
Status: Active
Number: EU4H-2022-PJ-06
Principal Investigator: Gregorc
Contribution allocated: €659,811.69
Implementing inter-specialty cancer training in 100 centers across Europe
INTERACT-EUROPE 100
Status: Active
Number: EU4H-2022-PJ-06
Principal Investigator: Various
Contribution allocated: n.a.
Turin Lyon Against Cancer
TL2C (ALCOTRA)
Status: Active
Number: 20126
Principal Investigator: Sapino
Contribution allocated: 998,200
Metrology for genomic profiling to support early cancer detection and precision medicine
GenomeMET
Status: Active
Number: https://www.genomemet.org/
Principal Investigator: Venesio
Contribution allocated: €120,000.00
Comprehensive Cancer Infrastructures 4 Europe
CCI4EU
Status: Active
Number: https://cci4eu.eu/
Principal Investigator: Gregorc
Contribution allocated: €28,625.00
Leveraging DNA repair and metabolic vulnerabilities to advance novel pharmacogenomics strategies
METAPRO
Status: Active
Number:
Principal Investigator: Arena
Contribution allocated: €399,850.00
An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum
ProCAncer-I
Status: Completed
Number: H2020-SC1-FA-DTS-2018-2020
Principal Investigator: Regge
Contribution allocated: €1,122,812.50
Integrated and standardized NGS workflows for personalized therapy
INSTAND-NGS4P
Status: Completed
Number: https://www.instandngs4p.eu/
Principal Investigator: Marchiò and Sapino
Contribution allocated: €6,390.00